Format
Items per page

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Senility

MedGen UID:
115903
Concept ID:
C0231337
Finding
2.

Blue Nevus

Usually a benign tumor, that commonly presents as a solitary blue nodule with spindled MELANOCYTES covered by smooth SKIN. Several variants have been identified, one variant being malignant. The blue color is caused by large, densely packed melanocytes deep in the DERMIS of the nevus. In CHILDREN, they usually occur on the BUTTOCKS and LUMBOSACRAL REGION and are referred to as cellular blue nevi. Malignant blue nevi are more commonly found on the SCALP. [from MeSH]

MedGen UID:
104930
Concept ID:
C0206736
Neoplastic Process
3.

Frequency

MedGen UID:
91210
Concept ID:
C0376249
Temporal Concept
4.

Neoplasm

An organ or organ-system abnormality that consists of uncontrolled autonomous cell-proliferation which can occur in any part of the body as a benign or malignant neoplasm (tumour). [from HPO]

MedGen UID:
10294
Concept ID:
C0027651
Neoplastic Process
5.

Malignant melanoma

Melanoma is the most serious type of skin cancer. Often the first sign of melanoma is a change in the size, shape, color, or feel of a mole. Most melanomas have a black or black-blue area. Melanoma may also appear as a new mole. It may be black, abnormal, or ugly looking.. Thinking of ABCDE can help you remember what to watch for:. - Asymmetry - the shape of one half does not match the other. - Border - the edges are ragged, blurred or irregular. - Color - the color is uneven and may include shades of black, brown and tan. - Diameter - there is a change in size, usually an increase. -Evolving - the mole has changed over the past few weeks or months. Surgery is the first treatment of all stages of melanoma. Other treatments include chemotherapy and radiation, biologic, and targeted therapies. Biologic therapy boosts your body's own ability to fight cancer. Targeted therapy uses substances that attack cancer cells without harming normal cells. NIH: National Cancer Institute.  [from MedlinePlus]

MedGen UID:
9944
Concept ID:
C0025202
Neoplastic Process
6.

Neoplasms

MedGen UID:
880980
Concept ID:
CN236628
Disease or Syndrome
7.

Absence

MedGen UID:
739164
Concept ID:
C1689985
Anatomical Abnormality
8.

Acral

MedGen UID:
615216
Concept ID:
C0439746
Spatial Concept
9.

Crisis

MedGen UID:
533658
Concept ID:
C0231224
Finding
10.

Cutaneous melanoma

The presence of a melanoma of the skin. [from HPO]

MedGen UID:
506658
Concept ID:
CN167782
Finding
11.

Melanoma

The presence of a melanoma, a malignant cancer originating from pigment producing melanocytes. Melanoma can originate from the skin or the pigmented layers of the eye (the uvea). [from HPO]

MedGen UID:
505377
Concept ID:
CN002586
Finding
12.

Disease regression

Return to a former state; a subsidence of the symptoms of a disease process; in cancer, a decrease in the size of a tumor or in the extent of cancer in the body. [from NCI]

MedGen UID:
195771
Concept ID:
C0684320
Pathologic Function
13.

Residual Disease

Cancer cells that remain after attempts to remove the cancer have been made. [from NCI_NCI-GLOSS]

MedGen UID:
108162
Concept ID:
C0543478
Neoplastic Process
14.

Stage 0 Skin Melanoma

Abnormal melanocytes (cells that make melanin, the pigment that gives skin its color) are found in the epidermis (outer layer of the skin). These abnormal melanocytes may become cancer and spread into nearby normal tissue. [from NCI_NCI-GLOSS]

MedGen UID:
87531
Concept ID:
C0346040
Neoplastic Process
15.

Frequent

Coming at short intervals or in great quantities. [from NCI]

MedGen UID:
87144
Concept ID:
C0332183
Temporal Concept
16.

Minimal Residual Disease

remainder of a tumor or a neoplasm/cancer after primary, potentially curative therapy. [from CRISP]

MedGen UID:
66115
Concept ID:
C0242596
Neoplastic Process
17.

Malignant melanoma of skin

A primary melanoma arising from atypical melanocytes in the skin. Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi. Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma. [from NCI]

MedGen UID:
57486
Concept ID:
C0151779
Neoplastic Process
18.

Nevus

Moles are growths on the skin. They happen when pigment cells in the skin, called melanocytes, grow in clusters. Moles are very common. Most people have between 10 and 40 moles. A person may develop new moles from time to time, usually until about age 40. In older people, they tend to fade away. Moles are usually pink, tan or brown. They can be flat or raised. They are usually round or oval and no larger than a pencil eraser. About one out of every ten people has at least one unusual (or atypical) mole that looks different from an ordinary mole. They are called dysplastic nevi. They may be more likely than ordinary moles to develop into melanoma, a type of skin cancer. You should have a health care professional check your moles if they look unusual, grow larger, change in color or outline, or in any other way. NIH: National Cancer Institute.  [from MedlinePlus]

MedGen UID:
45074
Concept ID:
C0027960
Neoplastic Process
19.

Melanocytic nevus

A oval and round, colored (usually medium-to dark brown, reddish brown, or flesh colored) lesion. Typically, a melanocytic nevus is less than 6 mm in diameter, but may be much smaller or larger. [from HPO]

MedGen UID:
14364
Concept ID:
C0027962
Neoplastic Process
20.

Cancer, Embryonal

MedGen UID:
199639
Concept ID:
C0751364
Neoplastic Process
Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center